Cancer Monoclonal Antibodies Market Scope And Analysis

  • Report Code : TIPRE00004907
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi del mercato degli anticorpi monoclonali contro il cancro e dei concorrenti entro il 2025-2031

Buy Now

Cancer Monoclonal Antibodies Market Report Cancer Monoclonal Antibodies Market Size and Share Cancer Monoclonal Antibodies Market Scope and Analysis

Cancer Monoclonal Antibodies Market Report Scope

Report Attribute Details
Market size in XX milioni di dollari USA nel 2024
Market Size by XX milioni di dollari entro il 2031
Global CAGR ()
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Tipo
  • anticorpi murini
  • anticorpi chimerici
  • anticorpi umanizzati
By Terapie
  • Bevacizumab
  • Rituximab
  • Trastuzumab
  • Cetuximab
  • Panitumumab
  • Altre terapie con anticorpi monoclonali
By Applicazione
  • cancro al seno
  • cancro al sangue
  • cancro al fegato
  • cancro al cervello
  • cancro colorettale
  • cancro ai polmoni
By Geografia
  • Nord America
  • Europa
  • Asia-Pacifico
  • Sud e Centro America
  • Medio Oriente e Africa
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Amgen Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline Plc
  • Johnson and Johnson Services, Inc.
  • Novartis AG
  • Eli Lilly and Company
  • Spectrum Pharmaceuticals, Inc.